Evidence map›Paper›PMID 34558330›Full record

ArticleJournal of diabetes science and technology2023

Six Digital Health Technologies That Will Transform Diabetes.

Alexander N Klonoff, Wei-An Andy Lee, Nicole Y Xu, Kevin T Nguyen, Ashley DuBord, David Kerr

Abstract read
In one paragraph

Article in Journal of diabetes science and technology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Expert Opinion on Optimizing Suboptimal Basal Insulin Titration in India: Addressing Challenges and Leveraging Digital Solutions.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alexander N KlonoffUniversity of Southern California, Los Angeles, CA, USA.ORCID 0000-0003-0297-6448
Wei-An Andy LeeLAC+USC Medical Center, Los Angeles, CA, USA.ORCID 0000-0002-2928-7338
Nicole Y XuDiabetes Technology Society, Burlingame, CA, USA.ORCID 0000-0001-9353-8819
Kevin T NguyenDiabetes Technology Society, Burlingame, CA, USA.ORCID 0000-0001-9102-6537
Ashley DuBordUniversity of California, San Francisco, CA, USA.ORCID 0000-0002-1478-7065
David KerrSansum Diabetes Research Institute, Santa Barbara, CA, USA.ORCID 0000-0003-1335-1857

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The digital health revolution is transforming the landscape of medicine through innovations in sensor data, software, and wireless communication tools. As one of the most prevalent chronic diseases in the United States, diabetes is particularly impactful as a model disease for which to apply innovation. As with any other newly developed technologies, there are three key questions to consider: 1) How can the technology benefit people with diabetes?, 2) What barriers must be overcome to further advance the technology?, and 3) How will the technology be applied in the future?. In this article, we highlight six areas of innovation that have the potential to reduce the burden of diabetes for individuals living with the condition and their families as well as provide measurable benefits for all stakeholders involved in diabetes care. The six technologies which have the potential to transform diabetes care are (i) telehealth, (ii) incorporation of diabetes digital data into the electronic health record, (iii) qualitative hypoglycemia alarms, (iv) artificial intelligence, (v) cybersecurity of diabetes devices, and (vi) diabetes registries. To be successful, a new digital health technology must be accessible and affordable. Furthermore, the people and communities that would most likely benefit from the technology must be willing to use the innovation in their management of diabetes.

Indexed as

Diabetes MellitusTelemedicineArtificial IntelligenceBiomedical TechnologyHumansSoftwareartificial intelligencecybersecuritydiabetesdigital healthelectronic health recordhypoglycemia alarmsregistriestelehealth

Identifiers

PMID34558330
PMCPMC9846384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.